Cameron B. Chiarot MBA, PhD
Executive Summary
I am a forward-thinking executive, educator, and scientist dedicated to establishing high-impact, interdisciplinary research ecosystems. My vision is to bridge the gap between rigorous scientific inquiry, external industry partnerships, and applied, outcomes-based pedagogy. Genuine equity requires dynamic planning and decisive action, which I have achieved through fostering collaborative, cross-faculty innovation and ensuring robust financial stewardship. I empower diverse teams to address complex challenges, secure strategic external funding, and execute initiatives that produce tangible educational, societal, and economic benefits.
Institutional Leadership & Capital Stewardship +
As a forward-thinking executive, I bridge rigorous institutional governance with robust financial stewardship. I have directed multi-million-dollar research and development infrastructures and led large-scale organizational transformations across complex private, public, and academic health sectors. By aligning applied innovation with overarching institutional goals, I build and empower high-performing, cross-disciplinary teams to execute complex projects and cultivate vital stakeholder partnerships.
Global Research Ecosystems & Academic Integration +
My work encompasses both high- and low-resource settings internationally, including Canada, the United States, the United Kingdom, and the Republic of Zambia. I am committed to fostering inclusive, interdisciplinary research environments and securing funding from external tri-council agencies and industry partners. Whether examining global disease surveillance systems or developing outcomes-focused curricula for higher education, my primary objective is to promote applied innovation and mentor the next generation of health systems leaders.
Interdisciplinary Scholarship & Professional Distinction +
My academic foundation comprises a PhD in Health Economics, Epidemiology, and Biostatistics from the University of Waterloo, during which I was nominated for the esteemed Governor General's Gold Medal in recognition of outstanding academic achievement and distinguished scholarship. I also possess an MBA in Economics, Finance, and Health Systems from the Schulich School of Business at York University, graduating with Distinction as a member of the Dean's List. Previously, I earned a BSc (Hon) in Psychology and Neuroscience from the University of Western Ontario, completing an honours thesis that ranked within the top 5%. Furthermore, I hold a certificate from the Executive Leadership Development Program in Healthcare Management at the University of Toronto's Rotman School of Management, in addition to my TCPS 2: CORE Certification from the Panel on Research Ethics.
Leadership & Scientific Core Competencies
The following chart outlines my hybrid expertise across advanced scientific methodologies and executive leadership, highlighting the years of applied experience driving health outcomes and financial acumen in each domain.
Leadership Philosophy & Collaborative Ecosystems
Interdisciplinary Synergy
Bridging institutional silos to align technical data scientists, clinical practitioners, and executive decision-makers.
'Sandbox' Environments
Cultivating psychological safety and methodological experimentation to push the boundaries of outcomes research.
Capacity Building
Mentoring high-performing teams and elevating the overarching analytical capabilities of the organization.
Equity & Inclusion
Driving systemic organizational equity by building diverse, high-performing teams and fostering a culture of belonging and equitable opportunity.
Executive & Scientific Impact
The following metrics represent my key operational, financial, scientific and regulatory milestones achieved through the application of data-driven strategy and executive leadership.
$100M
P&L Management
Oversight of operational capital and cross-functional institutional budgets.
$40M
R&D Infrastructure
Directed strategic planning and development of major clinical innovation centres.
6 Months
Regulatory Approval
Accelerated timeline for Health Canada Class III Medical Device authorizations.
17
Peer-Reviewed Publications
Authored high-impact methodologies with robust point estimate precision.
RWE & HEOR Portfolio
My applied research portfolio bridges advanced epidemiology and biostatistics with global health economics. Click on the strategic pillars below to explore the specific outcome targets, methodological frameworks, and insights of my evidence-generation corpus.
Health Economics & Systems Resilience +
Health System Utilization
- Focus: Environmental Shocks & Health Resilience | Method: Interrupted Time Series (ITS)
Insight: Evaluated utilization shifts and systemic resilience with high point estimate precision. - Focus: Econosyndemics & Health Stressors | Method: Structural Equation Modelling (SEM)
Insight: Identified systemic utilization drivers via structural causal models.
Maternal Continuum of Care
- Focus: Climate Shocks & Systemic Stressors | Method: Quasi-Experimental Design
Insight: Assessed continuum of care resilience against exogenous climate shocks.
Financial Burden & Economics of Scale
- Focus: Financial Burden of Free Healthcare | Method: Multivariable Regression
Insight: Quantified out-of-pocket financial burdens impacting healthcare utilization. - Focus: HIV Care Economies of Scale | Method: Cross-Sectional Analysis
Insight: Modeled scaling efficiencies and financial sustainability in care delivery.
Universal Health Coverage (UHC)
- Focus: Access as a Dimension of UHC | Method: Empirical Evaluation
Insight: Empirically assessed systemic access barriers inhibiting universal coverage.
Spatial & Infectious Disease Epidemiology +
Malaria Surveillance
- Focus: Malaria Denominators | Method: Spatial Catchment Methodology
Insight: Refined spatial catchment models to optimize surveillance denominators.
Maternal Healthcare Access
- Focus: Hydrological Shifts & Maternal Care | Method: Hydrological & Spatial Mapping
Insight: Mapped spatial barriers to maternal care access against hydrological data.
Universal Health Coverage (UHC)
- Focus: Spatial Inequities in Primary Care | Method: Location-Allocation Analysis
Insight: Analyzed primary care access inequities to inform location-allocation.
Geospatial Publication Integrity
- Focus: Nigerian Twinning Publication Bias | Method: Geospatial Meta-Analysis
Insight: Evaluated geospatial reporting integrity and spatial publication biases.
Mental Health
- Focus: COVID-19 Student Anxiety | Method: Systematic Review
Insight: Reviewed systemic mental health impacts using rigorous evidence synthesis.
Advanced Biostatistics & Trial Diagnostics +
HIV/AIDS Structural Risk
- Focus: PopART Risk & Friction Audit | Method: Frequentist & Bayesian Regression
Insight: Audited structural risk and trial friction with robust point estimate precision.
Pedagogical Innovation & Open-Source Architecture
A core component of my professional ecosystem is mentoring the next generation of health system leaders and building institutional analytical capacity. As the developer of the course “Value and Quality in Healthcare” (MHIA 6160) curriculum at York University’s Schulich School of Business, I bridge the gap between technical data science and healthcare administration. My pedagogical approach prioritizes the creation of interactive ‘sandbox’ learning environments built entirely on open-source R, RStudio, and public modelling interfaces, empowering students with accessible, reproducible tools for evidence-based decision-making.
Current Collaborative & Adjunct Appointments
These roles represent my active, collaborative, and professional academic engagements, maintained in tandem with my executive career pursuits:
- Research Scientist Collaborator | Imperial College London, London, UK
- Adjunct Professor | Schulich School of Business, York University, Toronto, Canada
- Sessional Lecturer | School of Public Health Sciences, University of Waterloo, Waterloo, Canada
Open to Strategic Opportunities
Dr. Chiarot is actively open to opportunities that leverage his unique intersection of rigorous health systems and outcomes research and executive leadership. With a proven track record of bridging the gap between advanced biostatistical modelling and organizational strategy, he is currently exploring roles including:
Senior Industry Leadership: Executive, Director, or Principal Scientist roles focusing on HEOR, RWE, and Market Access.
Executive Management: Strategic oversight of research infrastructure, clinical operations, applied innovation and intellectual property, P&L management, dynamic collaboration, mentorship, and stakeholder engagement.
Consultancy & Advising: Specialized expertise in public health initiatives, regulatory submissions, and advanced statistical and econometric modelling.
Academic Collaboration: Applied health systems and outcomes research and outcomes-based dynamic curriculum development (i.e., theory & applied)
{end}